CKD AGE: Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease

Sponsor
Centre Hospitalier Saint Joseph Saint Luc de Lyon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04827290
Collaborator
(none)
66
1
2
13
5.1

Study Details

Study Description

Brief Summary

Normal-protein and low-AGE through raw or rare proteins diet versus normal-protein and high-AGE diet in stage IIIa-b renal failure patients

Study Design

Study Type:
Interventional
Anticipated Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Assessment of the Effect of Restriction on Alimentary AGE (Advanced Glycation Products) in Progression of Chronic Kidney Disease (CKD)
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Normal-protein and low-AGE through raw or rare proteins diet

Normal-protein (0,8g/kg/day) and low-AGE through raw or rare proteins diet during 24 months

Behavioral: Low-AGE diet
Low-AGE diet during 24 months

Active Comparator: Normal-protein and AGE-rich diet

Normal-protein (0,8g/kg/day) and high-AGE through overcooked proteins diet during 24 months

Behavioral: High-AGE diet
High-AGE diet during 24 months

Outcome Measures

Primary Outcome Measures

  1. Glomerular Filtration Rate [At 24 months]

    Glomerular Filtration Rate estimated by the CKD-EPI formula with a blood sample

Secondary Outcome Measures

  1. Proteinuria [At 24 months]

    Proteinuria (g/24h) found in the 24-hour urine

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with a grade IIIA-B CKD (GFR with CKD-EPI ≥ 30 mL/min and < 60mL/min)

  • Informed consent signed

  • Aged 18 to 89 years

Exclusion Criteria:
  • Protected adult

  • Acute renal failure

  • Patient already on a low-AGE diet (< 1kU AGE/day) following a dietetic consultation

  • Current participation in another interventional research

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Saint Joseph Saint Luc Lyon France 69007

Sponsors and Collaborators

  • Centre Hospitalier Saint Joseph Saint Luc de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Saint Joseph Saint Luc de Lyon
ClinicalTrials.gov Identifier:
NCT04827290
Other Study ID Numbers:
  • CKD AGE
First Posted:
Apr 1, 2021
Last Update Posted:
Jan 18, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Saint Joseph Saint Luc de Lyon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2022